- Home
- LIQT vs ATHA Comparison
LIQT vs ATHA Comparison
Compare LIQT & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIQT
- ATHA
- Stock Information
- Founded
- LIQT 2004
- ATHA 2011
- Country
- LIQT Denmark
- ATHA United States
- Employees
- LIQT N/A
- ATHA N/A
- Industry
- LIQT Industrial Machinery/Components
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- LIQT Technology
- ATHA Health Care
- Exchange
- LIQT Nasdaq
- ATHA Nasdaq
- Market Cap
- LIQT 16.1M
- ATHA 14.8M
- IPO Year
- LIQT N/A
- ATHA 2020
- Fundamental
- Price
- LIQT $2.60
- ATHA $0.38
- Analyst Decision
- LIQT Strong Buy
- ATHA Hold
- Analyst Count
- LIQT 2
- ATHA 1
- Target Price
- LIQT $4.80
- ATHA $0.50
- AVG Volume (30 Days)
- LIQT 20.6K
- ATHA 177.7K
- Earning Date
- LIQT 11-13-2025
- ATHA 11-06-2025
- Dividend Yield
- LIQT N/A
- ATHA N/A
- EPS Growth
- LIQT N/A
- ATHA N/A
- EPS
- LIQT N/A
- ATHA N/A
- Revenue
- LIQT $15,459,242.00
- ATHA N/A
- Revenue This Year
- LIQT $36.89
- ATHA N/A
- Revenue Next Year
- LIQT $16.33
- ATHA N/A
- P/E Ratio
- LIQT N/A
- ATHA N/A
- Revenue Growth
- LIQT N/A
- ATHA N/A
- 52 Week Low
- LIQT $1.34
- ATHA $0.22
- 52 Week High
- LIQT $3.20
- ATHA $0.83
- Technical
- Relative Strength Index (RSI)
- LIQT 63.09
- ATHA 46.23
- Support Level
- LIQT $2.25
- ATHA $0.35
- Resistance Level
- LIQT $2.88
- ATHA $0.39
- Average True Range (ATR)
- LIQT 0.18
- ATHA 0.02
- MACD
- LIQT 0.06
- ATHA -0.00
- Stochastic Oscillator
- LIQT 72.00
- ATHA 50.00
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.